View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsWacker Chemie 配当と自社株買い配当金 基準チェック /46Wacker Chemie配当を支払う会社であり、現在の利回りは10.56%で、収益によって十分にカバーされています。主要情報10.6%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回り4.4%配当成長27.0%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向81%最近の配当と自社株買いの更新お知らせ • May 21Wacker Chemie Ag Approves DividendWacker Chemie AG announced that Annual Shareholders' Meeting on May 20, 2022 approved the highest dividend in the company's history. The dividend is EUR 8.00 per share, as proposed by the Executive Board and Supervisory Board.すべての更新を表示Recent updatesお知らせ • Oct 23+ 2 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025お知らせ • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.9% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 8.7% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (130% cash payout ratio). Profit margins are more than 30% lower than last year (9.9% net profit margin).Reported Earnings • Jul 30Second quarter 2023 earnings released: EPS: €2.38 (vs €7.67 in 2Q 2022)Second quarter 2023 results: EPS: €2.38 (down from €7.67 in 2Q 2022). Revenue: €1.75b (down 19% from 2Q 2022). Net income: €118.1m (down 69% from 2Q 2022). Profit margin: 6.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years, in line with the revenue forecast for the Chemicals industry in South America.お知らせ • Jul 21Wacker Chemie AG Lowers Sales Guidance for the Year 2023Wacker Chemie AG lowered sales guidance for the year 2023. The company now has the following expectations: Group sales for 2023 are likely to come in between EUR 6.5 billion and EUR 6.8 billion (previous guidance: between EUR 7 billion and EUR 7.5 billion).お知らせ • May 18+ 1 more updateWacker Chemie AG Announces Management ChangesThe Annual Shareholders' Meeting of Wacker Chemie AG approved Patrick Cramer is a new member of the Supervisory Board. He succeeds Franz-Josef Kortüm, a long-standing member of the Supervisory Board who stepped down at the end of the Annual Shareholders' Meeting for reasons of age. Cramer has a doctorate in biochemistry and is a former professor and dean at Ludwig-Maximilians-Universität in Munich. He currently works as director of the Max Planck Institute for Multidisciplinary Sciences in Göttingen. Cramer will take up his new assignment as president of the Max Planck Society in Munich at the end of June. The Supervisory Board's proposal to elect Prof. Andreas H. Biagosch, Dr. Gregor Biebl, Matthias Biebl, Prof. Patrick Cramer, Ann-Sophie Wacker, Dr. Peter-Alexander Wacker, Prof. Anna Weber and Dr. Susanne Weiss to the Supervisory Board until the 2028 Annual Shareholders' Meeting was adopted.お知らせ • May 10Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million.Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million on May 5, 2023. WACKER will continue and grow existing customer relationships maintained by ADL BioPharma in its capacity as CMO for fermentation-based products for the food, pharmaceutical and consumer goods industries. Wacker Chemie AG completed the acquisition of Biotechnology Assets, S.A from Kartesia Advisor LLP on May 5, 2023.お知らせ • Oct 29Wacker Chemie AG Provides Sales Guidance for the Full Year 2022Wacker Chemie AG provided sales guidance for the full year 2022. For full year 2022, the company expects sales between EUR 8.0 billion and EUR 8.5 billion.お知らせ • Oct 28Wacker Chemie AG, Annual General Meeting, May 17, 2023Wacker Chemie AG, Annual General Meeting, May 17, 2023.お知らせ • Oct 14+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2022 Final Results on Mar 14, 2023Wacker Chemie AG announced that they will report fiscal year 2022 final results on Mar 14, 2023Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to Mex$2,261, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 6x in the Chemicals industry in South America. Total loss to shareholders of 34% over the past year. Simply Wall St's valuation model estimates the intrinsic value at Mex$3,362 per share.Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: €7.66 (vs €3.69 in 2Q 2021)Second quarter 2022 results: EPS: €7.66 (up from €3.69 in 2Q 2021). Revenue: €2.17b (up 45% from 2Q 2021). Net income: €371.8m (up 112% from 2Q 2021). Profit margin: 17% (up from 12% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 1.1% compared to a 2.7% decline forecast for the industry in Mexico.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to Mex$3,064, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry globally. Simply Wall St's valuation model estimates the intrinsic value at Mex$2,853 per share.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to Mex$2,652, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry globally. Total loss to shareholders of 10% over the past year. Simply Wall St's valuation model estimates the intrinsic value at Mex$2,568 per share.お知らせ • May 21Wacker Chemie Ag Approves DividendWacker Chemie AG announced that Annual Shareholders' Meeting on May 20, 2022 approved the highest dividend in the company's history. The dividend is EUR 8.00 per share, as proposed by the Executive Board and Supervisory Board.Reported Earnings • May 01First quarter 2022 earnings released: EPS: €7.92 (vs €2.06 in 1Q 2021)First quarter 2022 results: EPS: €7.92 (up from €2.06 in 1Q 2021). Revenue: €2.08b (up 53% from 1Q 2021). Net income: €402.6m (up 278% from 1Q 2021). Profit margin: 19% (up from 7.8% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 6.8% while the industry in Mexico is not expected to grow.Reported Earnings • Mar 19Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €6.21b (up 32% from FY 2020). Net income: €806.9m (up 327% from FY 2020). Profit margin: 13% (up from 4.0% in FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 7.9%, compared to a 3.1% growth forecast for the industry in Mexico.お知らせ • Aug 06Wacker Chemie AG Revises Earnings Guidance for the Year 2021Wacker Chemie AG revised earnings guidance for the year 2021. For the year, the company expects sales of around EUR 5.5 billion for full-year 2021 The company had previously projected sales growth in the low double-digit percentage range.決済の安定と成長配当データの取得安定した配当: WCH Nの配当金支払いは、過去10年間 変動性 が高かった。増加する配当: WCH Nの配当金は過去10年間にわたって増加しています。配当利回り対市場Wacker Chemie 配当利回り対市場WCH N 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (WCH N)10.6%市場下位25% (MX)2.2%市場トップ25% (MX)5.8%業界平均 (Chemicals)4.4%アナリスト予想 (WCH N) (最長3年)4.4%注目すべき配当: WCH Nの配当金 ( 10.56% ) はMX市場の配当金支払者の下位 25% ( 2.22% ) よりも高くなっています。高配当: WCH Nの配当金 ( 10.56% ) はMX市場 ( 5.8% ) の配当支払者の中で上位 25% に入っています。株主への利益配当収益カバレッジ: 現在の配当性向（ 80.7% ）では、 WCH Nの支払いは利益によってカバーされています。株主配当金キャッシュフローカバレッジ: WCH Nは高い 現金配当性向 ( 129.6% ) のため、配当金の支払いはキャッシュフローで十分にカバーされていません。高配当企業の発掘7D1Y7D1Y7D1YMX 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/10/22 03:02終値2023/07/25 00:00収益2023/06/30年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Wacker Chemie AG 14 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。31 アナリスト機関Gerhard SchwarzBaader Helvea Equity ResearchKonstantin WiechertBaader Helvea Equity ResearchLaura Lopez PinedaBaader Helvea Equity Research28 その他のアナリストを表示
お知らせ • May 21Wacker Chemie Ag Approves DividendWacker Chemie AG announced that Annual Shareholders' Meeting on May 20, 2022 approved the highest dividend in the company's history. The dividend is EUR 8.00 per share, as proposed by the Executive Board and Supervisory Board.
お知らせ • Oct 23+ 2 more updatesWacker Chemie AG to Report Fiscal Year 2024 Results on Mar 12, 2025Wacker Chemie AG announced that they will report fiscal year 2024 results on Mar 12, 2025
お知らせ • Oct 27+ 4 more updatesWacker Chemie AG to Report Q2, 2024 Results on Jul 26, 2024Wacker Chemie AG announced that they will report Q2, 2024 results on Jul 26, 2024
New Risk • Jul 31New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 9.9% Last year net profit margin: 17% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings are forecast to decline by an average of 8.7% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (130% cash payout ratio). Profit margins are more than 30% lower than last year (9.9% net profit margin).
Reported Earnings • Jul 30Second quarter 2023 earnings released: EPS: €2.38 (vs €7.67 in 2Q 2022)Second quarter 2023 results: EPS: €2.38 (down from €7.67 in 2Q 2022). Revenue: €1.75b (down 19% from 2Q 2022). Net income: €118.1m (down 69% from 2Q 2022). Profit margin: 6.7% (down from 18% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to stay flat during the next 3 years, in line with the revenue forecast for the Chemicals industry in South America.
お知らせ • Jul 21Wacker Chemie AG Lowers Sales Guidance for the Year 2023Wacker Chemie AG lowered sales guidance for the year 2023. The company now has the following expectations: Group sales for 2023 are likely to come in between EUR 6.5 billion and EUR 6.8 billion (previous guidance: between EUR 7 billion and EUR 7.5 billion).
お知らせ • May 18+ 1 more updateWacker Chemie AG Announces Management ChangesThe Annual Shareholders' Meeting of Wacker Chemie AG approved Patrick Cramer is a new member of the Supervisory Board. He succeeds Franz-Josef Kortüm, a long-standing member of the Supervisory Board who stepped down at the end of the Annual Shareholders' Meeting for reasons of age. Cramer has a doctorate in biochemistry and is a former professor and dean at Ludwig-Maximilians-Universität in Munich. He currently works as director of the Max Planck Institute for Multidisciplinary Sciences in Göttingen. Cramer will take up his new assignment as president of the Max Planck Society in Munich at the end of June. The Supervisory Board's proposal to elect Prof. Andreas H. Biagosch, Dr. Gregor Biebl, Matthias Biebl, Prof. Patrick Cramer, Ann-Sophie Wacker, Dr. Peter-Alexander Wacker, Prof. Anna Weber and Dr. Susanne Weiss to the Supervisory Board until the 2028 Annual Shareholders' Meeting was adopted.
お知らせ • May 10Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million.Wacker Chemie AG acquired Biotechnology Assets, S.A from Kartesia Advisor LLP for €100 million on May 5, 2023. WACKER will continue and grow existing customer relationships maintained by ADL BioPharma in its capacity as CMO for fermentation-based products for the food, pharmaceutical and consumer goods industries. Wacker Chemie AG completed the acquisition of Biotechnology Assets, S.A from Kartesia Advisor LLP on May 5, 2023.
お知らせ • Oct 29Wacker Chemie AG Provides Sales Guidance for the Full Year 2022Wacker Chemie AG provided sales guidance for the full year 2022. For full year 2022, the company expects sales between EUR 8.0 billion and EUR 8.5 billion.
お知らせ • Oct 28Wacker Chemie AG, Annual General Meeting, May 17, 2023Wacker Chemie AG, Annual General Meeting, May 17, 2023.
お知らせ • Oct 14+ 3 more updatesWacker Chemie AG to Report Fiscal Year 2022 Final Results on Mar 14, 2023Wacker Chemie AG announced that they will report fiscal year 2022 final results on Mar 14, 2023
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to Mex$2,261, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 6x in the Chemicals industry in South America. Total loss to shareholders of 34% over the past year. Simply Wall St's valuation model estimates the intrinsic value at Mex$3,362 per share.
Reported Earnings • Aug 03Second quarter 2022 earnings released: EPS: €7.66 (vs €3.69 in 2Q 2021)Second quarter 2022 results: EPS: €7.66 (up from €3.69 in 2Q 2021). Revenue: €2.17b (up 45% from 2Q 2021). Net income: €371.8m (up 112% from 2Q 2021). Profit margin: 17% (up from 12% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 1.1% compared to a 2.7% decline forecast for the industry in Mexico.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to Mex$3,064, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 13x in the Chemicals industry globally. Simply Wall St's valuation model estimates the intrinsic value at Mex$2,853 per share.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to Mex$2,652, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry globally. Total loss to shareholders of 10% over the past year. Simply Wall St's valuation model estimates the intrinsic value at Mex$2,568 per share.
お知らせ • May 21Wacker Chemie Ag Approves DividendWacker Chemie AG announced that Annual Shareholders' Meeting on May 20, 2022 approved the highest dividend in the company's history. The dividend is EUR 8.00 per share, as proposed by the Executive Board and Supervisory Board.
Reported Earnings • May 01First quarter 2022 earnings released: EPS: €7.92 (vs €2.06 in 1Q 2021)First quarter 2022 results: EPS: €7.92 (up from €2.06 in 1Q 2021). Revenue: €2.08b (up 53% from 1Q 2021). Net income: €402.6m (up 278% from 1Q 2021). Profit margin: 19% (up from 7.8% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 6.8% while the industry in Mexico is not expected to grow.
Reported Earnings • Mar 19Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: €6.21b (up 32% from FY 2020). Net income: €806.9m (up 327% from FY 2020). Profit margin: 13% (up from 4.0% in FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 7.9%, compared to a 3.1% growth forecast for the industry in Mexico.
お知らせ • Aug 06Wacker Chemie AG Revises Earnings Guidance for the Year 2021Wacker Chemie AG revised earnings guidance for the year 2021. For the year, the company expects sales of around EUR 5.5 billion for full-year 2021 The company had previously projected sales growth in the low double-digit percentage range.